BNT327, DOCETAXEL
BNT327-07
Phase 2 small_molecule active
Quick answer
BNT327, DOCETAXEL for Non-small Cell Lung Cancer is a Phase 2 program (small_molecule) at BioNTech Manufacturing GmbH with 1 ClinicalTrials.gov record(s).
Program details
- Company
- BioNTech Manufacturing GmbH
- Indication
- Non-small Cell Lung Cancer
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active